ArticleClinical case reports2026

Clinical and Biochemical Improvement After Switching From Agalsidase Alfa to Beta in a Boy With Classic Fabry Disease: A Case Report.

Nobuhiko Koga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.